AKT1 and B-cell chronic lymphocytic leukemia: The PI3K/AKT signaling pathway plays a central role in the pathogenesis of RT, with increased expression of PI3K and frequent activation of AKT observed in high-risk CLL patients and in over 50% of RT cases [50,77,80].